AKT1 and urinary bladder carcinoma: Two independent studies of high throughput genomic sequencing of human bladder cancer tissues uncovered that frequent alterations of RTKs/RAS/MAPK and PI3K/Akt/mTOR signaling pathways were critical features of bladder cancer [12, 19], suggesting that both pathways could be important targets in the treatment of bladder cancer [20].